{"nctId":"NCT02891837","briefTitle":"L-citrulline for Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass for Heart Defects","startDateStruct":{"date":"2016-08","type":"ACTUAL"},"conditions":["Acute Lung Injury"],"count":189,"armGroups":[{"label":"L-citrulline","type":"EXPERIMENTAL","interventionNames":["Drug: L-citrulline"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Placebo"]}],"interventions":[{"name":"L-citrulline","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects, parents, or legal guardian of the subject who are willing and able to sign informed consent\n* Male and female subjects aged ≤18 years of age\n* Infants, children and adolescents undergoing cardiopulmonary bypass (CPB) for repair of a large unrestrictive VSD, an ostium primum ASD, or a partial or complete AVSD\n* Pre-operative echocardiogram which confirms the cardiovascular anatomy and defect to be surgically repaired\n\nExclusion Criteria:\n\n* Evidence of pulmonary artery or vein abnormalities on the pre-operative echocardiogram that will not be addressed surgically. Specific abnormalities excluded include the following:\n\n  * Significant pulmonary artery narrowing not amenable to surgical correction\n  * Previous pulmonary artery stent placement\n  * Significant left sided AV valve regurgitation not amenable to surgical correction\n  * Pulmonary venous return abnormalities not amenable to surgical correction\n  * Pulmonary vein stenosis not amenable to surgical correction\n* Preoperative requirement for mechanical ventilation or intravenous inotrope support\n* Presence of fixed or idiopathic pulmonary hypertension (i.e. Eisenmenger's Syndrome) prior to surgical repair\n* Pre-operative use of medications to treat pulmonary hypertension\n* Pregnancy; Females of child-bearing potential must be willing to participate an acceptable method of birth control for the duration of study participation (e.g. oral contraceptive, hormonal implant, intra-uterine device)\n* Any condition which, in the opinion of the investigator, might interfere with the study objectives\n* Participation in another clinical trial within 30 days of Screening or while participating in the current study, including the 28 days of follow-up post study drug administration","healthyVolunteers":false,"sex":"ALL","maximumAge":"18 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"A Composite Variable Consisting of the Longer of Either (1) Length of Time on Mechanical Ventilation or (2) Length of Inotrope Use.","description":"Mechanical ventilation (MV) = invasive or noninvasive MV incl. bilevel (biphasic) positive airway pressure or continuous positive airway pressure. Inotrope use = medications considered within the derivation of total inotrope score (dopamine, dobutamine, milrinone, epinephrine, phenylephrine, norepinephrine). Both measures recorded until earliest of subject hospital discharge or Day 28.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3351.1","spread":"5230.8"},{"groupId":"OG001","value":"3549.6","spread":"6069.1"}]}]}]},{"type":"SECONDARY","title":"Length of Time on Mechanical Ventilation","description":"The same definitions and analyses as described for the primary endpoint will be applied.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2398.4","spread":"2031.8"},{"groupId":"OG001","value":"5236.9","spread":"4714.7"}]}]}]},{"type":"SECONDARY","title":"Length of Time on Positive Pressure Ventilation","description":"The same definitions and analyses as described for the primary endpoint will be applied.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2018.7","spread":"4918.5"},{"groupId":"OG001","value":"1285.6","spread":"2354.8"}]}]}]},{"type":"SECONDARY","title":"Length of Time of Inotrope Use","description":"The same definitions and analyses as described for the primary endpoint will be applied.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2726.4","spread":"3637.5"},{"groupId":"OG001","value":"3167.3","spread":"6035.2"}]}]}]},{"type":"SECONDARY","title":"Inotrope Score","description":"Inotrope score is reflective of the pharmacological support required by the cardiovascular system and is a good predictor of mortality and morbidity in patients undergoing bypass surgery. A lower inotrope score represents less pharmacological support and would indicate a lower risk for a poor clinical outcome. Therefore, any treatment effect would be indicated by a lower inotrope score in the citrulline group when compared to the placebo group.\n\nIn this study, the score was calculated each hour post-operatively from the time of separation from bypass until the completion of study drug. Additionally, the total inotrope score over time until Day 28 or hospital discharge was derived. Inotrope score was calculated using the following formula:\n\nTotal inotrope score = Dopamine dose (µg/kg/min) + Dobutamine dose (µg/kg/min) + 10 \\* Milrinone dose (µg/kg/min) + 100 \\* Epinephrine dose (µg/kg/min) + 100 \\* Phenylephrine dose (µg/kg/min) + 100 \\* Norepinephrine dose (µg/kg/min).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1691.6","spread":"11420.8"},{"groupId":"OG001","value":"583.6","spread":"4879.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5076.2","spread":"38880.0"},{"groupId":"OG001","value":"537.1","spread":"4870.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5983.4","spread":"39369.2"},{"groupId":"OG001","value":"1258.2","spread":"11744.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6044.1","spread":"39566.9"},{"groupId":"OG001","value":"1257.4","spread":"11744.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6044.0","spread":"39567.0"},{"groupId":"OG001","value":"1257.3","spread":"11744.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5983.5","spread":"39369.2"},{"groupId":"OG001","value":"1243.4","spread":"11677.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5983.3","spread":"39369.2"},{"groupId":"OG001","value":"1243.4","spread":"11677.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5983.2","spread":"2007.7"},{"groupId":"OG001","value":"39369.2","spread":"13688.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5983.4","spread":"39369.2"},{"groupId":"OG001","value":"2007.1","spread":"13688.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5983.0","spread":"39369.3"},{"groupId":"OG001","value":"2007.0","spread":"13688.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5983.1","spread":"39369.2"},{"groupId":"OG001","value":"2007.0","spread":"13688.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5983.5","spread":"39369.2"},{"groupId":"OG001","value":"2006.8","spread":"13688.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5983.1","spread":"39369.2"},{"groupId":"OG001","value":"2006.7","spread":"13688.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3255.8","spread":"16449.2"},{"groupId":"OG001","value":"2006.6","spread":"13688.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3255.8","spread":"16449.2"},{"groupId":"OG001","value":"2006.5","spread":"13688.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3255.4","spread":"16449.2"},{"groupId":"OG001","value":"2006.6","spread":"13688.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3255.7","spread":"16449.2"},{"groupId":"OG001","value":"2006.5","spread":"13688.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3255.4","spread":"16449.2"},{"groupId":"OG001","value":"2006.2","spread":"13688.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3254.9","spread":"16449.3"},{"groupId":"OG001","value":"2006.1","spread":"13688.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3254.9","spread":"16449.3"},{"groupId":"OG001","value":"2005.7","spread":"13688.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2143.6","spread":"12376.3"},{"groupId":"OG001","value":"2107.8","spread":"13707.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2143.2","spread":"12376.3"},{"groupId":"OG001","value":"2005.7","spread":"13688.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2143.2","spread":"12376.3"},{"groupId":"OG001","value":"2005.6","spread":"13688.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2143.0","spread":"12376.4"},{"groupId":"OG001","value":"2005.3","spread":"13688.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2142.8","spread":"12376.4"},{"groupId":"OG001","value":"2005.2","spread":"13688.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2142.8","spread":"12376.4"},{"groupId":"OG001","value":"2004.9","spread":"13688.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2041.4","spread":"2004.9"},{"groupId":"OG001","value":"12352.5","spread":"13688.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2041.1","spread":"12352.5"},{"groupId":"OG001","value":"2005.4","spread":"13688.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2041.1","spread":"12352.5"},{"groupId":"OG001","value":"2004.7","spread":"13688.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2041.1","spread":"12352.5"},{"groupId":"OG001","value":"2004.7","spread":"13688.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2040.9","spread":"12352.6"},{"groupId":"OG001","value":"2004.6","spread":"13688.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2041.0","spread":"12352.5"},{"groupId":"OG001","value":"2004.7","spread":"13688.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2041.1","spread":"12352.5"},{"groupId":"OG001","value":"2004.6","spread":"13688.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2041.0","spread":"12352.5"},{"groupId":"OG001","value":"2004.6","spread":"13688.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2040.9","spread":"12352.5"},{"groupId":"OG001","value":"2004.4","spread":"13688.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2041.1","spread":"12352.5"},{"groupId":"OG001","value":"2004.5","spread":"13688.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2040.9","spread":"12352.5"},{"groupId":"OG001","value":"2004.4","spread":"13688.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2040.9","spread":"12352.6"},{"groupId":"OG001","value":"2004.4","spread":"13688.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2040.9","spread":"12352.6"},{"groupId":"OG001","value":"2004.3","spread":"13688.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1012.5","spread":"7071.8"},{"groupId":"OG001","value":"2004.3","spread":"13688.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1012.5","spread":"7071.8"},{"groupId":"OG001","value":"1282.1","spread":"8736.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1012.5","spread":"7071.8"},{"groupId":"OG001","value":"780.0","spread":"7378.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1012.4","spread":"7071.8"},{"groupId":"OG001","value":"779.9","spread":"7378.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1012.4","spread":"7071.8"},{"groupId":"OG001","value":"780.1","spread":"7378.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1012.3","spread":"7071.8"},{"groupId":"OG001","value":"780.0","spread":"7378.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1012.1","spread":"7071.9"},{"groupId":"OG001","value":"780.0","spread":"7378.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1012.1","spread":"7071.8"},{"groupId":"OG001","value":"780.0","spread":"7378.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1012.1","spread":"7071.9"},{"groupId":"OG001","value":"779.8","spread":"7378.4"}]}]}]},{"type":"SECONDARY","title":"Hemodynamic Improvement: Heart Rate","description":"Heart rate at hours 1, 2, 4, 12, 24 and 48.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"80.1","spread":"67.9"},{"groupId":"OG001","value":"83.6","spread":"60.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"111.2","spread":"45.7"},{"groupId":"OG001","value":"116.0","spread":"46.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"130.4","spread":"27.7"},{"groupId":"OG001","value":"133.5","spread":"20.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"120.9","spread":"22.0"},{"groupId":"OG001","value":"161.9","spread":"17.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"122.2","spread":"22.2"},{"groupId":"OG001","value":"118.3","spread":"14.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"125.9","spread":"18.7"},{"groupId":"OG001","value":"125.4","spread":"21.0"}]}]}]},{"type":"SECONDARY","title":"Hemodynamic Improvement: Systemic Arterial Blood Pressure","description":"Systemic arterial blood pressure at hours 1, 2, 4, 12, 24 and 48.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18.4","spread":"16.2"},{"groupId":"OG001","value":"15.3","spread":"14.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"31.7","spread":"17.9"},{"groupId":"OG001","value":"32.5","spread":"18.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.4","spread":"12.1"},{"groupId":"OG001","value":"42.1","spread":"12.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"39.7","spread":"12.1"},{"groupId":"OG001","value":"40.7","spread":"10.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"41.0","spread":"12.2"},{"groupId":"OG001","value":"40.1","spread":"10.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"40.3","spread":"15.8"},{"groupId":"OG001","value":"42.1","spread":"11.6"}]}]}]},{"type":"SECONDARY","title":"Hemodynamic Improvement: Oxygen Saturation","description":"Oxygen saturation at hours 1, 2, 4, 12, 24 and 48.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"97.2","spread":"7.9"},{"groupId":"OG001","value":"95.7","spread":"15.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"98.6","spread":"4.6"},{"groupId":"OG001","value":"97.6","spread":"10.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"98.5","spread":"2.1"},{"groupId":"OG001","value":"98.1","spread":"2.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"97.9","spread":"2.4"},{"groupId":"OG001","value":"97.6","spread":"2.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"97.1","spread":"4.0"},{"groupId":"OG001","value":"97.6","spread":"2.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"97.6","spread":"2.8"},{"groupId":"OG001","value":"97.8","spread":"2.6"}]}]}]},{"type":"SECONDARY","title":"Hemodynamic Improvement: Central Venous Pressure","description":"Central venous pressure at hours 1, 2, 4, 12, 24 and 48.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.2","spread":"20.1"},{"groupId":"OG001","value":"12.9","spread":"28.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.3","spread":"5.6"},{"groupId":"OG001","value":"13.2","spread":"23.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.1","spread":"23.7"},{"groupId":"OG001","value":"13.2","spread":"27.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.7","spread":"4.1"},{"groupId":"OG001","value":"9.0","spread":"3.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.9","spread":"5.4"},{"groupId":"OG001","value":"9.8","spread":"3.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.8","spread":"6.2"},{"groupId":"OG001","value":"9.6","spread":"8.3"}]}]}]},{"type":"SECONDARY","title":"Thoracotomy Output","description":"The thoracotomy output is defined as the total volume of chest tube drainage recorded in cc prior to discontinuation of chest intubation. The total postoperative duration (in hours) that the chest tube is used will be calculated as the time from the end of the surgery to the time the chest tube is removed. If an additional chest tube is required or reinserted (until discharge from the hospital or at Day 28) the duration that the additional chest tube was used (from time of insertion to time of removal) will be added to the time the original chest tube was used for the total postoperative duration. If a subject did not use any chest tube the duration is set to 0. As a sensitivity analysis, subjects with no use of chest tube will be excluded. For subjects who died before discharge from the hospital or before Day 28, respectively, the observed duration of chest tube drainage will be used.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"206.41","spread":"137.26"},{"groupId":"OG001","value":"198.94","spread":"143.85"}]}]}]},{"type":"SECONDARY","title":"Length of Time of Intubation","description":"The length will be derived as the time in hours from separation from CPB until discontinuation of intubation. Any duration of re-use of intubation will continue to accrue. If a subject did not use any intubation the length is set to 0. As a sensitivity analysis, subjects with no use of intubations will be excluded. For subjects who died before discharge from the hospital or before Day 28, respectively, the observed length of time on intubation will be used. As sensitivity analyses subjects who died will (1) be excluded from analysis and (2) be assigned a length of time on intubation of 28 days.\n\nFor the length of time on intubation the same analyses as described for the primary endpoint will be applied.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1600.4","spread":"4488.9"},{"groupId":"OG001","value":"1303.9","spread":"4408.3"}]}]}]},{"type":"SECONDARY","title":"Length of Pediatric Intensive Care Unit (PICU) Stay","description":"The length of PICU stay will be calculated as the total number of days postoperative until discharge from PICU. For subjects who died before discharge from PICU or before Day 28, respectively, the observed length of PICU stay will be used. As sensitivity analyses subjects who died will (1) be excluded from analysis and (2) be assigned a length of PICU stay of 28 days. For the length of PICU stay the same analyses as described for the primary endpoint will be applied.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.3","spread":"8.5"},{"groupId":"OG001","value":"6.5","spread":"9.2"}]}]}]},{"type":"SECONDARY","title":"Length of Time on Vasodilators","description":"Length of time on vasodilators will be measured from first use following separation from bypass, until the subject is discharged from the hospital or at Day 28. The length will be derived as the time in hours from separation from CPB until discontinuation of all vasodilators.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1668.4","spread":"5751.6"},{"groupId":"OG001","value":"611.3","spread":"1212.5"}]}]}]},{"type":"SECONDARY","title":"Length of Hospitalization","description":"The length of hospitalization will be calculated as the total number of days postoperative until discharge from the hospital. For subjects who died before discharge from the hospital or before Day 28, respectively, the observed length of hospitalization will be used. As sensitivity analyses subjects who died will (1) be excluded from analysis and (2) be assigned a length of hospitalization of 28 days. The same analyses as described for the primary endpoint will be applied.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.1","spread":"5.1"},{"groupId":"OG001","value":"3.9","spread":"3.9"}]}]}]},{"type":"SECONDARY","title":"Patients With Plasma Concentrations of Citrulline","description":"Plasma citrulline concentrations will be assessed in both treatment groups to determine the number of patients who reach the therapeutic sustained target plasma citrulline level of ≥100 μmol/L. Blood collection for assessment of plasma citrulline concentrations will be taken prior to surgery, during surgery, 30 minutes post-decannulation after CPB (prior to bolus and 5 minutes after bolus), at the specified post-operative time points (6h, 12h, 24h, 48h), and at hospital discharge or Day 28, whichever occurs first.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2179.6","spread":"1046.8"},{"groupId":"OG001","value":"26.4","spread":"9.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1808.9","spread":"12549.4"},{"groupId":"OG001","value":"27.6","spread":"11.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1387.8","spread":"4957.5"},{"groupId":"OG001","value":"27.8","spread":"11.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"146.6","spread":"67.3"},{"groupId":"OG001","value":"20.3","spread":"10.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"123.8","spread":"41.3"},{"groupId":"OG001","value":"18.5","spread":"8.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"102.1","spread":"42.6"},{"groupId":"OG001","value":"14.9","spread":"6.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"68.2","spread":"44.9"},{"groupId":"OG001","value":"12.1","spread":"5.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21.9","spread":"29.5"},{"groupId":"OG001","value":"16.9","spread":"6.2"}]}]}]},{"type":"SECONDARY","title":"Occurrence of Adverse and Serious Adverse Events","description":"Pre-treatment adverse events and treatment adverse events will be analyzed separately. The number of affected subjects will be reported.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"68","spread":null},{"groupId":"OG001","value":"62","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19","spread":null},{"groupId":"OG001","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"68","spread":null},{"groupId":"OG001","value":"61","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null},{"groupId":"OG001","value":"6","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With Refractory Hypotension","description":"Refractory hypotension is defined as a 20% drop of mean arterial pressure (MAP) below specific age-related criteria for more than 30 minutes. The number of subjects with any refractory hypotension from end of surgery until 48 hours will be compared between groups.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"POST_HOC","title":"A Composite Variable Consisting of the Longer of Either (1) Length of Time on Mechanical Ventilation or (2) Length of Inotrope Use.","description":"Mechanical ventilation (MV) = invasive or noninvasive MV incl. bilevel (biphasic) positive airway pressure or continuous positive airway pressure. Inotrope use = medications considered within the derivation of total inotrope score (dopamine, dobutamine, milrinone, epinephrine, phenylephrine, norepinephrine). Both measures recorded until earliest of subject hospital discharge or Day 28.\n\nNote: data are reported for post-hoc analyses based on a modified full analysis set (mFAS) targeting the US population for a 48-hour treatment period. Analysis method used was quartiles based, but followed prescribed statistical analysis plan methods. This is because chosen endpoints did not appear to be valid in the ex-US population due to differences in physician decision making. In the US, extubation occurs as soon as a patient's physical condition permits (only more severely ill children remain on mechanical ventilation); conversely, in ex-US sites, children remain on mechanical ventilation.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1484.9","spread":"1317.1"},{"groupId":"OG001","value":"1730.7","spread":"1435.5"}]}]}]},{"type":"POST_HOC","title":"Length of Time on Mechanical Ventilation","description":"The same definitions and analyses as described for the primary endpoint will be applied.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"420.2","spread":"585.1"},{"groupId":"OG001","value":"649.7","spread":"786.4"}]}]}]},{"type":"POST_HOC","title":"Length of Time on Positive Pressure Ventilation","description":"The same definitions and analyses as described for the primary endpoint will be applied.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"200.9","spread":"560.5"},{"groupId":"OG001","value":"358.0","spread":"758.5"}]}]}]},{"type":"POST_HOC","title":"Length of Time of Inotrope Use","description":"The same definitions and analyses as described for the primary endpoint will be applied.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1428.6","spread":"1344.6"},{"groupId":"OG001","value":"1653.1","spread":"1485.7"}]}]}]},{"type":"POST_HOC","title":"Inotrope Score","description":"Inotrope score is reflective of the pharmacological support required by the cardiovascular system and is a good predictor of mortality and morbidity in patients undergoing bypass surgery. A lower inotrope score represents less pharmacological support and would indicate a lower risk for a poor clinical outcome. Therefore, any treatment effect would be indicated by a lower inotrope score in the citrulline group when compared to the placebo group.\n\nIn this study, the score was calculated each hour post-operatively from the time of separation from bypass until the completion of study drug. Additionally, the total inotrope score over time until Day 28 or hospital discharge was derived. Inotrope score was calculated using the following formula:\n\nTotal inotrope score = Dopamine dose (µg/kg/min) + Dobutamine dose (µg/kg/min) + 10 \\* Milrinone dose (µg/kg/min) + 100 \\* Epinephrine dose (µg/kg/min) + 100 \\* Phenylephrine dose (µg/kg/min) + 100 \\* Norepinephrine dose (µg/kg/min).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14.7","spread":"43.0"},{"groupId":"OG001","value":"17.4","spread":"44.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.2","spread":"98.0"},{"groupId":"OG001","value":"13.5","spread":"58.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.5","spread":"4.2"},{"groupId":"OG001","value":"4.5","spread":"3.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.6","spread":"2.6"},{"groupId":"OG001","value":"4.4","spread":"3.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.7","spread":"2.8"},{"groupId":"OG001","value":"4.4","spread":"2.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.7","spread":"2.8"},{"groupId":"OG001","value":"4.4","spread":"2.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.6","spread":"2.7"},{"groupId":"OG001","value":"4.5","spread":"3.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.4","spread":"2.4"},{"groupId":"OG001","value":"4.5","spread":"3.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.4","spread":"2.4"},{"groupId":"OG001","value":"4.4","spread":"3.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.4","spread":"2.4"},{"groupId":"OG001","value":"4.3","spread":"3.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.3","spread":"2.5"},{"groupId":"OG001","value":"4.1","spread":"2.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.4","spread":"3.5"},{"groupId":"OG001","value":"4.0","spread":"3.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.3","spread":"2.8"},{"groupId":"OG001","value":"3.8","spread":"3.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.1","spread":"2.5"},{"groupId":"OG001","value":"3.7","spread":"3.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.1","spread":"2.6"},{"groupId":"OG001","value":"3.7","spread":"3.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.0","spread":"2.6"},{"groupId":"OG001","value":"3.5","spread":"3.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.1","spread":"2.8"},{"groupId":"OG001","value":"3.8","spread":"4.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.0","spread":"2.7"},{"groupId":"OG001","value":"3.4","spread":"3.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.8","spread":"2.7"},{"groupId":"OG001","value":"3.4","spread":"3.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.9","spread":"3.2"},{"groupId":"OG001","value":"3.1","spread":"3.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.6","spread":"2.8"},{"groupId":"OG001","value":"3.1","spread":"3.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.3","spread":"2.7"},{"groupId":"OG001","value":"2.7","spread":"3.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.2","spread":"3.2"},{"groupId":"OG001","value":"2.9","spread":"4.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.1","spread":"3.1"},{"groupId":"OG001","value":"2.3","spread":"3.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.8","spread":"2.6"},{"groupId":"OG001","value":"2.4","spread":"4.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.7","spread":"2.8"},{"groupId":"OG001","value":"1.9","spread":"3.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.5","spread":"2.7"},{"groupId":"OG001","value":"1.8","spread":"2.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.4","spread":"2.3"},{"groupId":"OG001","value":"2.0","spread":"3.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.3","spread":"2.3"},{"groupId":"OG001","value":"1.5","spread":"2.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.4","spread":"2.5"},{"groupId":"OG001","value":"1.4","spread":"2.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.2","spread":"2.3"},{"groupId":"OG001","value":"1.4","spread":"2.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.2","spread":"2.3"},{"groupId":"OG001","value":"1.5","spread":"3.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.2","spread":"2.4"},{"groupId":"OG001","value":"1.4","spread":"2.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":"2.2"},{"groupId":"OG001","value":"1.3","spread":"2.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.2","spread":"2.3"},{"groupId":"OG001","value":"1.2","spread":"2.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":"2.2"},{"groupId":"OG001","value":"1.3","spread":"2.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":"2.3"},{"groupId":"OG001","value":"1.2","spread":"2.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":"2.1"},{"groupId":"OG001","value":"1.2","spread":"2.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":"2.1"},{"groupId":"OG001","value":"1.1","spread":"2.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":"2.1"},{"groupId":"OG001","value":"1.1","spread":"2.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":"2.1"},{"groupId":"OG001","value":"1.1","spread":"2.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":"2.3"},{"groupId":"OG001","value":"1.1","spread":"2.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.8","spread":"1.9"},{"groupId":"OG001","value":"1.0","spread":"2.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":"2.2"},{"groupId":"OG001","value":"1.2","spread":"2.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":"2.0"},{"groupId":"OG001","value":"1.0","spread":"2.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.6","spread":"1.4"},{"groupId":"OG001","value":"1.1","spread":"2.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.6","spread":"1.4"},{"groupId":"OG001","value":"1.0","spread":"2.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":"1.2"},{"groupId":"OG001","value":"0.7","spread":"1.5"}]}]}]},{"type":"POST_HOC","title":"Hemodynamic Improvement: Heart Rate","description":"Heart rate will be calculated using the absolute changes from baseline at hours 1, 2, 4, 12, 24 and 48 and will be compared between groups using an ANOVA with a fixed effect for treatment group and baseline level. Summary tables describing descriptive measurements will be generated for absolute values and absolute change from baseline values for all observed time points.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-43.9","spread":"78.6"},{"groupId":"OG001","value":"-40.6","spread":"66.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-14.1","spread":"50.0"},{"groupId":"OG001","value":"1.1","spread":"43.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.0","spread":"27.3"},{"groupId":"OG001","value":"18.5","spread":"24.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.8","spread":"19.6"},{"groupId":"OG001","value":"5.4","spread":"16.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.1","spread":"21.3"},{"groupId":"OG001","value":"3.3","spread":"20.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.8","spread":"21.2"},{"groupId":"OG001","value":"7.1","spread":"26.6"}]}]}]},{"type":"POST_HOC","title":"Hemodynamic Improvement: Systemic Arterial Blood Pressure","description":"Systemic arterial blood pressure will be calculated using the absolute changes from baseline at hours 1, 2, 4, 12, 24 and 48 and will be compared between groups using an ANOVA with a fixed effect for treatment group and baseline level. Summary tables describing descriptive measurements will be generated for absolute values and absolute change from baseline values for all observed time points.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-17.9","spread":"13.2"},{"groupId":"OG001","value":"-22.3","spread":"17.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.8","spread":"19.1"},{"groupId":"OG001","value":"-4.0","spread":"17.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.3","spread":"12.5"},{"groupId":"OG001","value":"8.9","spread":"13.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.6","spread":"11.7"},{"groupId":"OG001","value":"7.2","spread":"13.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.8","spread":"12.9"},{"groupId":"OG001","value":"8.4","spread":"11.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.5","spread":"17.9"},{"groupId":"OG001","value":"7.6","spread":"14.5"}]}]}]},{"type":"POST_HOC","title":"Hemodynamic Improvement: Oxygen Saturation","description":"Oxygen saturation will be calculated using the absolute changes from baseline at hours 1, 2, 4, 12, 24 and 48 and will be compared between groups using an ANOVA with a fixed effect for treatment group and baseline level. Summary tables describing descriptive measurements will be generated for absolute values and absolute change from baseline values for all observed time points.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.3","spread":"6.2"},{"groupId":"OG001","value":"-1.8","spread":"18.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.3","spread":"9.4"},{"groupId":"OG001","value":"1.5","spread":"9.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.4","spread":"8.8"},{"groupId":"OG001","value":"0.7","spread":"9.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.8","spread":"8.4"},{"groupId":"OG001","value":"0.7","spread":"8.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.2","spread":"9.9"},{"groupId":"OG001","value":"0.2","spread":"8.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":"9.6"},{"groupId":"OG001","value":"1.1","spread":"10.3"}]}]}]},{"type":"POST_HOC","title":"Hemodynamic Improvement: Central Venous Pressure","description":"Central venous pressure will be calculated using the absolute changes from baseline at hours 1, 2, 4, 12, 24 and 48 and will be compared between groups using an ANOVA with a fixed effect for treatment group and baseline level. Summary tables describing descriptive measurements will be generated for absolute values and absolute change from baseline values for all observed time points.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-10.0","spread":"48.8"},{"groupId":"OG001","value":"-6.8","spread":"45.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.5","spread":"47.4"},{"groupId":"OG001","value":"-5.2","spread":"43.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.7","spread":"36.5"},{"groupId":"OG001","value":"-5.2","spread":"41.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-10.4","spread":"58.6"},{"groupId":"OG001","value":"-7.7","spread":"41.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.1","spread":"11.2"},{"groupId":"OG001","value":"-8.3","spread":"43.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.3","spread":"17.3"},{"groupId":"OG001","value":"6.2","spread":"20.8"}]}]}]},{"type":"POST_HOC","title":"Thoracotomy Output","description":"The thoracotomy output is defined as the total volume of chest tube drainage recorded in cc prior to discontinuation of chest intubation. The total postoperative duration (in hours) that the chest tube is used will be calculated as the time from the end of the surgery to the time the chest tube is removed. If an additional chest tube is required or reinserted (until discharge from the hospital or at Day 28) the duration that the additional chest tube was used (from time of insertion to time of removal) will be added to the time the original chest tube was used for the total postoperative duration. If a subject did not use any chest tube the duration is set to 0. As a sensitivity analysis, subjects with no use of chest tube will be excluded. For subjects who died before discharge from the hospital or before Day 28, respectively, the observed duration of chest tube drainage will be used.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"209.42","spread":"141.35"},{"groupId":"OG001","value":"194.35","spread":"124.41"}]}]}]},{"type":"POST_HOC","title":"Length of Time of Intubation","description":"The length will be derived as the time in hours from separation from CPB until discontinuation of intubation. Any duration of re-use of intubation will continue to accrue. If a subject did not use any intubation the length is set to 0. As a sensitivity analysis, subjects with no use of intubations will be excluded. For subjects who died before discharge from the hospital or before Day 28, respectively, the observed length of time on intubation will be used. As sensitivity analyses subjects who died will (1) be excluded from analysis and (2) be assigned a length of time on intubation of 28 days.\n\nFor the length of time on intubation the same analyses as described for the primary endpoint will be applied.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"329.9","spread":"432.6"},{"groupId":"OG001","value":"386.5","spread":"556.6"}]}]}]},{"type":"POST_HOC","title":"Length of Pediatric Intensive Care Unit (PICU) Stay","description":"The length of PICU stay will be calculated as the total number of days postoperative until discharge from PICU. For subjects who died before discharge from PICU or before Day 28, respectively, the observed length of PICU stay will be used. As sensitivity analyses subjects who died will (1) be excluded from analysis and (2) be assigned a length of PICU stay of 28 days. For the length of PICU stay the same analyses as described for the primary endpoint will be applied.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.6","spread":"9.2"},{"groupId":"OG001","value":"7.1","spread":"10.7"}]}]}]},{"type":"POST_HOC","title":"Length of Time on Vasodilators","description":"Length of time on vasodilators will be measured from first use following separation from bypass, until the subject is discharged from the hospital or at Day 28. The length will be derived as the time in hours from separation from CPB until discontinuation of all vasodilators.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"617.9","spread":"910.0"},{"groupId":"OG001","value":"624.8","spread":"1077.1"}]}]}]},{"type":"POST_HOC","title":"Length of Hospitalization","description":"The length of hospitalization will be calculated as the total number of days postoperative until discharge from the hospital. For subjects who died before discharge from the hospital or before Day 28, respectively, the observed length of hospitalization will be used. As sensitivity analyses subjects who died will (1) be excluded from analysis and (2) be assigned a length of hospitalization of 28 days. The same analyses as described for the primary endpoint will be applied.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.9","spread":"2.6"},{"groupId":"OG001","value":"4.8","spread":"2.5"}]}]}]},{"type":"POST_HOC","title":"Patients With Plasma Concentrations of Citrulline","description":"Plasma citrulline concentrations will be assessed in both treatment groups to determine the number of patients who reach the therapeutic sustained target plasma citrulline level of ≥100 μmol/L. Blood collection for assessment of plasma citrulline concentrations will be taken prior to surgery, during surgery, 30 minutes post-decannulation after CPB (prior to bolus and 5 minutes after bolus), at the specified post-operative time points (6h, 12h, 24h, 48h), and at hospital discharge or Day 28, whichever occurs first.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2264.6","spread":"890.1"},{"groupId":"OG001","value":"26.7","spread":"9.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2625.4","spread":"16391.9"},{"groupId":"OG001","value":"25.4","spread":"8.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"760.1","spread":"369.5"},{"groupId":"OG001","value":"25.7","spread":"9.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"133.7","spread":"39.2"},{"groupId":"OG001","value":"18.8","spread":"8.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"125.6","spread":"32.9"},{"groupId":"OG001","value":"17.6","spread":"7.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"108.4","spread":"43.0"},{"groupId":"OG001","value":"14.6","spread":"6.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.3","spread":"49.6"},{"groupId":"OG001","value":"12.4","spread":"6.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.5","spread":"44.3"},{"groupId":"OG001","value":"16.2","spread":"6.4"}]}]}]},{"type":"POST_HOC","title":"Occurrence of Adverse and Serious Adverse Events","description":"Pre-treatment adverse events and treatment adverse events will be analyzed separately. The number affected subjects will be reported.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"48","spread":null},{"groupId":"OG001","value":"30","spread":null},{"groupId":"OG002","value":"20","spread":null},{"groupId":"OG003","value":"10","spread":null},{"groupId":"OG004","value":"47","spread":null},{"groupId":"OG005","value":"30","spread":null},{"groupId":"OG006","value":"15","spread":null},{"groupId":"OG007","value":"8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"6","spread":null},{"groupId":"OG002","value":"7","spread":null},{"groupId":"OG003","value":"3","spread":null},{"groupId":"OG004","value":"9","spread":null},{"groupId":"OG005","value":"6","spread":null},{"groupId":"OG006","value":"3","spread":null},{"groupId":"OG007","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"48","spread":null},{"groupId":"OG001","value":"30","spread":null},{"groupId":"OG002","value":"20","spread":null},{"groupId":"OG003","value":"10","spread":null},{"groupId":"OG004","value":"46","spread":null},{"groupId":"OG005","value":"29","spread":null},{"groupId":"OG006","value":"15","spread":null},{"groupId":"OG007","value":"8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"2","spread":null},{"groupId":"OG002","value":"7","spread":null},{"groupId":"OG003","value":"4","spread":null},{"groupId":"OG004","value":"2","spread":null},{"groupId":"OG005","value":"2","spread":null},{"groupId":"OG006","value":"4","spread":null},{"groupId":"OG007","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null},{"groupId":"OG002","value":"1","spread":null},{"groupId":"OG003","value":"1","spread":null},{"groupId":"OG004","value":"0","spread":null},{"groupId":"OG005","value":"1","spread":null},{"groupId":"OG006","value":"0","spread":null},{"groupId":"OG007","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"2","spread":null},{"groupId":"OG002","value":"7","spread":null},{"groupId":"OG003","value":"4","spread":null},{"groupId":"OG004","value":"2","spread":null},{"groupId":"OG005","value":"2","spread":null},{"groupId":"OG006","value":"4","spread":null},{"groupId":"OG007","value":"3","spread":null}]}]}]},{"type":"POST_HOC","title":"Number of Patients With Refractory Hypotension","description":"Refractory hypotension is defined as a 20% drop of mean arterial pressure (MAP) below specific age-related criteria for more than 30 minutes. The number of subjects with any refractory hypotension from end of surgery until 48 hours will be compared between groups.","classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":11,"n":99},"commonTop":["Pain","Pyrexia","Hypertension","Constipation","Hypokalaemia"]}}}